Daisy Nie

Daisy Nie is a recognized leader in the biopharmaceutical industry with extensive experience in the development, commercialization, and lifecycle management of biologic therapies, including therapeutic proteins and cell/gene therapy products. Currently, she serves as the Executive Director of Cell Therapy Analytical Development and Operations at Novartis, where she leads a team dedicated to developing analytical methods for release and characterization of Novartis Cell Therapy pipeline. Before joining Novartis, Daisy held various leadership positions at Thermo Fisher Scientific, Bristol Myers Squibb, and AstraZeneca. She earned her Ph.D. in Microbiology and Immunology from Drexel University College of Medicine.